论文部分内容阅读
观察尼莫通输液治疗脑梗塞的临床疗效及患者在心电方面对尼莫通的耐受性。方法将６０例脑梗塞患者随机分为治疗组（静滴尼莫通）及对照组（静滴复方丹参），疗程结束后观察其疗效；并对治疗组患者给药前、给药过程中、给药结束时行心电监护。结果治疗组患者症状、体征的恢复优于对照组；在控制适当给药浓度的前提下，尼莫通输液对心率、心脏传导系统及心肌供血无不良影响。
To observe the clinical efficacy of nimotong infusion in the treatment of cerebral infarction and the patient’s tolerance to nimotop in electrocardiogram. Methods Sixty patients with cerebral infarction were randomly divided into treatment group (intravenous nimotop) and control group (intravenous infusion of Salvia miltiorrhiza). After treatment, the curative effect was observed. Before treatment, ECG end of the line when the drug custody. Results The recovery of symptoms and signs of the treatment group was better than that of the control group. Nimodipine infusion had no adverse effects on heart rate, cardiac conduction system and myocardial blood supply under the control of appropriate dosage.